{"nct_id":"NCT03710564","title":"Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections","status":"TERMINATED","status_verified_date":"2023-01","start_date":"2018-10-30","start_date_type":"ACTUAL","primary_completion_date":"2020-12-21","primary_completion_date_type":"ACTUAL","completion_date":"2021-07-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}